Moderna Inc. stock underperforms Friday when compared to competitors

Shares of Moderna Inc. MRNA, -2.17% slipped 2.17% to $73.94 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA, +0.39% rising 0.39% to 28,606.31 and the NASDAQ Composite Index COMP, -0.36% falling 0.36% to 11,671.56. This was the stock’s third consecutive day of losses. Moderna Inc. closed $21.27 short of its 52-week high ($95.21), which the company achieved on July 17th.

The stock underperformed when compared to some of its competitors Friday, as AbbVie Inc. ABBV, +1.22% rose 1.22% to $86.27 and Amgen Inc. AMGN, +0.30% rose 0.30% to $235.72. Trading volume (4.7 M) remained 5.7 million below its 50-day average volume of 10.3 M.

Editor’s Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

Read More Here...

Bookmark the permalink.

Comments are closed.